Oncotelic Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!About OTLC
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
CEOVuong Trieu
CEOVuong Trieu
Employees40
Employees40
HeadquartersAgoura Hills, California
HeadquartersAgoura Hills, California
Founded1988
Founded1988
Employees40
Employees40
OTLC Key Statistics
Market cap41.47M
Market cap41.47M
Price-Earnings ratio-21.95
Price-Earnings ratio-21.95
Dividend yield—
Dividend yield—
Average volume149.82K
Average volume149.82K
High today$0.0949
High today$0.0949
Low today$0.09
Low today$0.09
Open price$0.0922
Open price$0.0922
Volume2.50K
Volume2.50K
52 Week high$0.11
52 Week high$0.11
52 Week low$0.024
52 Week low$0.024
Stock Snapshot
As of today, Oncotelic Therapeutics(OTLC) shares are valued at $0.09. The company's market cap stands at 41.47M, with a P/E ratio of -21.95.
On 2025-12-12, Oncotelic Therapeutics(OTLC) stock traded between a low of $0.09 and a high of $0.09. Shares are currently priced at $0.09, which is +1.7% above the low and -3.6% below the high.
The Oncotelic Therapeutics(OTLC)'s current trading volume is 2.5K, compared to an average daily volume of 149.82K.
In the last year, Oncotelic Therapeutics(OTLC) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.
In the last year, Oncotelic Therapeutics(OTLC) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.